Systemic immunosuppressive therapies for children with refractory atopic dermatitis: a large real-life cohort study

Br J Dermatol. 2023 Sep 15;189(4):492-494. doi: 10.1093/bjd/ljad222.

Authors

Ayelet Ollech^{1

2}, Rachel Lefferdink³, Anjani Sheth³, Alli Blumstein³, Divya Ramachandran³, Anette Wagner^{1

3

4}, Brandi Kenner-Bell^{1

3

4}, Anthony J Mancini^{1

3

4}, Sarah Chamlin^{1

3

4}, Lacey L Kruse^{1

3

4}, Stephanie M Rangel³, Amy S Paller^{1

3

4}

Affiliations

¹ Division of Dermatology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
² Department of Dermatology, Sheba Medical Center Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
³ Departments of Dermatology.
⁴ Pediatrics, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.

PMID: 37405446
DOI: 10.1093/bjd/ljad222

No abstract available

MeSH terms

Child
Cohort Studies
Dermatitis, Atopic* / drug therapy
Humans
Immunosuppression Therapy
Immunosuppressive Agents / therapeutic use

Substances

Immunosuppressive Agents